| | Press and Media

Press Releases

view by year
PRESS RELEASEAugust 05, 2014
NanoString Technologies Releases Financial Results for Second Quarter of 2014
read more
PRESS RELEASEAugust 05, 2014
NanoString Technologies Receives Market Approval from the Australian Therapeutic Goods Administration for its Prosigna Breast Cancer Prognostic Gene Signature Assay
read more
PRESS RELEASEJuly 29, 2014
NanoString Technologies Introduces New Universal Junction Probe Design for Detecting Gene Fusions
read more
PRESS RELEASEJuly 21, 2014
NanoString Technologies to Release Second Quarter 2014 Financial Results and Host Conference Call on Tuesday, August 5, 2014
read more
PRESS RELEASEJune 03, 2014
NanoString Technologies Enters into Biomarker Companion Diagnostic Collaboration with Celgene Corporation to Support Development of REVLIMID as Treatment for Patients with Diffuse Large B-Cell Lymphoma
read more
PRESS RELEASEMay 07, 2014
NanoString Technologies Releases First Quarter 2014 Financial Results
read more
PRESS RELEASEMay 06, 2014
NanoString Technologies Receives Canadian Market Approval for its Prosigna Breast Cancer Prognostic Gene Signature Assay
read more

Media Coverage

view by year
September 10, 2013
NCI Scientists Identify Targets for Melanoma Immunotherapy
read more
September 10, 2013
In BD Deal, NanoString Looks to Broaden Appeal to Single-Cell Genomics Researchers
read more
April 17, 2013
NanoString Nabs License to Liver Cancer Gene Signature
read more
February 19, 2013
NanoString Starts Selling First Breast Cancer Test in EU - (on Xconomy)
read more